Vidal Urbinati AM

ORCID: 0000-0001-8656-3098 · 5 papers in corpus
2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics14010001

In this study, we conducted a comparative analysis of demographic, histopathological, and sonographic characteristics between pre- and postmenopausal women diagnosed with endometrial cancer, while also examining sonographic and anthropometr…

2023
Healthcare (Basel, Switzerland) ·doi:10.3390/healthcare11071058

Fertility-sparing treatment (FTS) of endometrial cancer (EC) has a high rate of remission but also a high rate of relapse (10-88%). Many women still wish to conceive at the time of relapse, but results regarding retreatment are still lackin…

2022
Annals of surgical oncology ·doi:10.1245/s10434-022-12353-y

BackgroundThe term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical, …

2022
Cancers ·doi:10.3390/cancers14092170

BackgroundThe prevalence of reaches up to 5% in women younger than 40 years. Therefore, the fertility preservation should be the goal of the clinical practice in women with desire of pregnancy and low-risk features. The aim of this study is…

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12122904

This study aims to analyze the sensitivity of vaginosonography (VGS) and magnetic resonance imaging (MRI) in the preoperative local evaluation of early-stage cervical cancers and to assess their accuracy in the detection of tumors, size of …